The global market for Gemcitabine Hydrochloride was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Gemcitabine hydrochloride is a chemotherapy drug used to treat various types of cancer, including pancreatic, lung, breast, ovarian, and bladder cancer. It is a nucleoside analogue that interferes with the growth and spread of cancer cells in the body. Gemcitabine hydrochloride is typically administered intravenously and works by inhibiting the synthesis of DNA and RNA, thereby preventing cancer cells from dividing and multiplying. It is often used in combination with other chemotherapy drugs to enhance its effectiveness. Common side effects of gemcitabine hydrochloride include nausea, vomiting, fatigue, and low blood cell counts.
North American market for Gemcitabine Hydrochloride is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gemcitabine Hydrochloride is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Gemcitabine Hydrochloride include Hubei Banbantian Pharmaceutical, Shandong Anhong Pharmaceutical, Shanghai Acebright Pharmaceuticals, Jiangsu Chia Tai Qingjiang Pharmaceutical, ScinoPharm Taiwan, Intas Pharmaceuticals, Euticals, Gland Pharma, SMS Pharmaceuticals, Cipla, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gemcitabine Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine Hydrochloride.
The Gemcitabine Hydrochloride market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gemcitabine Hydrochloride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gemcitabine Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Hubei Banbantian Pharmaceutical
Shandong Anhong Pharmaceutical
Shanghai Acebright Pharmaceuticals
Jiangsu Chia Tai Qingjiang Pharmaceutical
ScinoPharm Taiwan
Intas Pharmaceuticals
Euticals
Gland Pharma
SMS Pharmaceuticals
Cipla
Shilpa Medicare
Fresenius Kabi Oncology
Dr Reddy's Laboratories
Teva Pharmaceutical Industries
Hetero Drugs
Emcure Pharmaceuticals
Cadila Pharmaceuticals
Aarti Drugs
by Type
Powder
Solvent
by Application
Cancer
Tumor
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gemcitabine Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gemcitabine Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gemcitabine Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Gemcitabine Hydrochloride 麻豆原创 Overview
1.1 Product Definition
1.2 Gemcitabine Hydrochloride by Type
1.2.1 Global Gemcitabine Hydrochloride 麻豆原创 Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Powder
1.2.3 Solvent
1.3 Gemcitabine Hydrochloride by Application
1.3.1 Global Gemcitabine Hydrochloride 麻豆原创 Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Cancer
1.3.3 Tumor
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Gemcitabine Hydrochloride Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Gemcitabine Hydrochloride Production Estimates and Forecasts (2020-2031)
1.4.4 Global Gemcitabine Hydrochloride 麻豆原创 Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Gemcitabine Hydrochloride Production 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Gemcitabine Hydrochloride Production Value 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Key Players of Gemcitabine Hydrochloride, Industry Ranking, 2023 VS 2024
2.4 Global Gemcitabine Hydrochloride 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Gemcitabine Hydrochloride Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Gemcitabine Hydrochloride, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gemcitabine Hydrochloride, Product Offered and Application
2.8 Global Key Manufacturers of Gemcitabine Hydrochloride, Date of Enter into This Industry
2.9 Gemcitabine Hydrochloride 麻豆原创 Competitive Situation and Trends
2.9.1 Gemcitabine Hydrochloride 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Gemcitabine Hydrochloride Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gemcitabine Hydrochloride Production by Region
3.1 Global Gemcitabine Hydrochloride Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Gemcitabine Hydrochloride Production Value by Region (2020-2031)
3.2.1 Global Gemcitabine Hydrochloride Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Gemcitabine Hydrochloride by Region (2026-2031)
3.3 Global Gemcitabine Hydrochloride Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Gemcitabine Hydrochloride Production Volume by Region (2020-2031)
3.4.1 Global Gemcitabine Hydrochloride Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Gemcitabine Hydrochloride by Region (2026-2031)
3.5 Global Gemcitabine Hydrochloride 麻豆原创 Price Analysis by Region (2020-2025)
3.6 Global Gemcitabine Hydrochloride Production and Value, Year-over-Year Growth
3.6.1 North America Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Gemcitabine Hydrochloride Production Value Estimates and Forecasts (2020-2031)
4 Gemcitabine Hydrochloride Consumption by Region
4.1 Global Gemcitabine Hydrochloride Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Gemcitabine Hydrochloride Consumption by Region (2020-2031)
4.2.1 Global Gemcitabine Hydrochloride Consumption by Region (2020-2025)
4.2.2 Global Gemcitabine Hydrochloride Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Gemcitabine Hydrochloride Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Gemcitabine Hydrochloride Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gemcitabine Hydrochloride Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Gemcitabine Hydrochloride Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Gemcitabine Hydrochloride Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Gemcitabine Hydrochloride Production by Type (2020-2031)
5.1.1 Global Gemcitabine Hydrochloride Production by Type (2020-2025)
5.1.2 Global Gemcitabine Hydrochloride Production by Type (2026-2031)
5.1.3 Global Gemcitabine Hydrochloride Production 麻豆原创 Share by Type (2020-2031)
5.2 Global Gemcitabine Hydrochloride Production Value by Type (2020-2031)
5.2.1 Global Gemcitabine Hydrochloride Production Value by Type (2020-2025)
5.2.2 Global Gemcitabine Hydrochloride Production Value by Type (2026-2031)
5.2.3 Global Gemcitabine Hydrochloride Production Value 麻豆原创 Share by Type (2020-2031)
5.3 Global Gemcitabine Hydrochloride Price by Type (2020-2031)
6 Segment by Application
6.1 Global Gemcitabine Hydrochloride Production by Application (2020-2031)
6.1.1 Global Gemcitabine Hydrochloride Production by Application (2020-2025)
6.1.2 Global Gemcitabine Hydrochloride Production by Application (2026-2031)
6.1.3 Global Gemcitabine Hydrochloride Production 麻豆原创 Share by Application (2020-2031)
6.2 Global Gemcitabine Hydrochloride Production Value by Application (2020-2031)
6.2.1 Global Gemcitabine Hydrochloride Production Value by Application (2020-2025)
6.2.2 Global Gemcitabine Hydrochloride Production Value by Application (2026-2031)
6.2.3 Global Gemcitabine Hydrochloride Production Value 麻豆原创 Share by Application (2020-2031)
6.3 Global Gemcitabine Hydrochloride Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hubei Banbantian Pharmaceutical
7.1.1 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Company Information
7.1.2 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.1.3 Hubei Banbantian Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hubei Banbantian Pharmaceutical Main Business and 麻豆原创s Served
7.1.5 Hubei Banbantian Pharmaceutical Recent Developments/Updates
7.2 Shandong Anhong Pharmaceutical
7.2.1 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Company Information
7.2.2 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.2.3 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Shandong Anhong Pharmaceutical Main Business and 麻豆原创s Served
7.2.5 Shandong Anhong Pharmaceutical Recent Developments/Updates
7.3 Shanghai Acebright Pharmaceuticals
7.3.1 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.3.2 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.3.3 Shanghai Acebright Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Shanghai Acebright Pharmaceuticals Main Business and 麻豆原创s Served
7.3.5 Shanghai Acebright Pharmaceuticals Recent Developments/Updates
7.4 Jiangsu Chia Tai Qingjiang Pharmaceutical
7.4.1 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Company Information
7.4.2 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Product Portfolio
7.4.3 Jiangsu Chia Tai Qingjiang Pharmaceutical Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jiangsu Chia Tai Qingjiang Pharmaceutical Main Business and 麻豆原创s Served
7.4.5 Jiangsu Chia Tai Qingjiang Pharmaceutical Recent Developments/Updates
7.5 ScinoPharm Taiwan
7.5.1 ScinoPharm Taiwan Gemcitabine Hydrochloride Company Information
7.5.2 ScinoPharm Taiwan Gemcitabine Hydrochloride Product Portfolio
7.5.3 ScinoPharm Taiwan Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.5.4 ScinoPharm Taiwan Main Business and 麻豆原创s Served
7.5.5 ScinoPharm Taiwan Recent Developments/Updates
7.6 Intas Pharmaceuticals
7.6.1 Intas Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.6.2 Intas Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.6.3 Intas Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Intas Pharmaceuticals Main Business and 麻豆原创s Served
7.6.5 Intas Pharmaceuticals Recent Developments/Updates
7.7 Euticals
7.7.1 Euticals Gemcitabine Hydrochloride Company Information
7.7.2 Euticals Gemcitabine Hydrochloride Product Portfolio
7.7.3 Euticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Euticals Main Business and 麻豆原创s Served
7.7.5 Euticals Recent Developments/Updates
7.8 Gland Pharma
7.8.1 Gland Pharma Gemcitabine Hydrochloride Company Information
7.8.2 Gland Pharma Gemcitabine Hydrochloride Product Portfolio
7.8.3 Gland Pharma Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Gland Pharma Main Business and 麻豆原创s Served
7.8.5 Gland Pharma Recent Developments/Updates
7.9 SMS Pharmaceuticals
7.9.1 SMS Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.9.2 SMS Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.9.3 SMS Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.9.4 SMS Pharmaceuticals Main Business and 麻豆原创s Served
7.9.5 SMS Pharmaceuticals Recent Developments/Updates
7.10 Cipla
7.10.1 Cipla Gemcitabine Hydrochloride Company Information
7.10.2 Cipla Gemcitabine Hydrochloride Product Portfolio
7.10.3 Cipla Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Cipla Main Business and 麻豆原创s Served
7.10.5 Cipla Recent Developments/Updates
7.11 Shilpa Medicare
7.11.1 Shilpa Medicare Gemcitabine Hydrochloride Company Information
7.11.2 Shilpa Medicare Gemcitabine Hydrochloride Product Portfolio
7.11.3 Shilpa Medicare Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Shilpa Medicare Main Business and 麻豆原创s Served
7.11.5 Shilpa Medicare Recent Developments/Updates
7.12 Fresenius Kabi Oncology
7.12.1 Fresenius Kabi Oncology Gemcitabine Hydrochloride Company Information
7.12.2 Fresenius Kabi Oncology Gemcitabine Hydrochloride Product Portfolio
7.12.3 Fresenius Kabi Oncology Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Fresenius Kabi Oncology Main Business and 麻豆原创s Served
7.12.5 Fresenius Kabi Oncology Recent Developments/Updates
7.13 Dr Reddy's Laboratories
7.13.1 Dr Reddy's Laboratories Gemcitabine Hydrochloride Company Information
7.13.2 Dr Reddy's Laboratories Gemcitabine Hydrochloride Product Portfolio
7.13.3 Dr Reddy's Laboratories Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Dr Reddy's Laboratories Main Business and 麻豆原创s Served
7.13.5 Dr Reddy's Laboratories Recent Developments/Updates
7.14 Teva Pharmaceutical Industries
7.14.1 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Company Information
7.14.2 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Product Portfolio
7.14.3 Teva Pharmaceutical Industries Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Teva Pharmaceutical Industries Main Business and 麻豆原创s Served
7.14.5 Teva Pharmaceutical Industries Recent Developments/Updates
7.15 Hetero Drugs
7.15.1 Hetero Drugs Gemcitabine Hydrochloride Company Information
7.15.2 Hetero Drugs Gemcitabine Hydrochloride Product Portfolio
7.15.3 Hetero Drugs Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Hetero Drugs Main Business and 麻豆原创s Served
7.15.5 Hetero Drugs Recent Developments/Updates
7.16 Emcure Pharmaceuticals
7.16.1 Emcure Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.16.2 Emcure Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.16.3 Emcure Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Emcure Pharmaceuticals Main Business and 麻豆原创s Served
7.16.5 Emcure Pharmaceuticals Recent Developments/Updates
7.17 Cadila Pharmaceuticals
7.17.1 Cadila Pharmaceuticals Gemcitabine Hydrochloride Company Information
7.17.2 Cadila Pharmaceuticals Gemcitabine Hydrochloride Product Portfolio
7.17.3 Cadila Pharmaceuticals Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Cadila Pharmaceuticals Main Business and 麻豆原创s Served
7.17.5 Cadila Pharmaceuticals Recent Developments/Updates
7.18 Aarti Drugs
7.18.1 Aarti Drugs Gemcitabine Hydrochloride Company Information
7.18.2 Aarti Drugs Gemcitabine Hydrochloride Product Portfolio
7.18.3 Aarti Drugs Gemcitabine Hydrochloride Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Aarti Drugs Main Business and 麻豆原创s Served
7.18.5 Aarti Drugs Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gemcitabine Hydrochloride Industry Chain Analysis
8.2 Gemcitabine Hydrochloride Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gemcitabine Hydrochloride Production Mode & Process Analysis
8.4 Gemcitabine Hydrochloride Sales and 麻豆原创ing
8.4.1 Gemcitabine Hydrochloride Sales Channels
8.4.2 Gemcitabine Hydrochloride Distributors
8.5 Gemcitabine Hydrochloride Customer Analysis
9 Gemcitabine Hydrochloride 麻豆原创 Dynamics
9.1 Gemcitabine Hydrochloride Industry Trends
9.2 Gemcitabine Hydrochloride 麻豆原创 Drivers
9.3 Gemcitabine Hydrochloride 麻豆原创 Challenges
9.4 Gemcitabine Hydrochloride 麻豆原创 Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Hubei Banbantian Pharmaceutical
Shandong Anhong Pharmaceutical
Shanghai Acebright Pharmaceuticals
Jiangsu Chia Tai Qingjiang Pharmaceutical
ScinoPharm Taiwan
Intas Pharmaceuticals
Euticals
Gland Pharma
SMS Pharmaceuticals
Cipla
Shilpa Medicare
Fresenius Kabi Oncology
Dr Reddy's Laboratories
Teva Pharmaceutical Industries
Hetero Drugs
Emcure Pharmaceuticals
Cadila Pharmaceuticals
Aarti Drugs
听
听
*If Applicable.
